Some investigations have demonstrated that the two compounds, acting as agonists of the GSH antioxidant system, well prevent oxidative stress and reduce heart damage in some animal cardiomyopathy models, for instance, the ISO-induced myocardium infarction model [159, 160]
Another aspect, resulting from modern and innovative research on arteriosclerosis, is the influence of the NL-GHK-Cu peptide on the activation of the vascular endothelial growth factor VEGF, whose activation in arteriosclerotic disease processes has so far been considered pathological
For TrimRx patients on a compounded semaglutide or tirzepatide protocol, the GLP-1 is doing the major metabolic work with strong evidence support
That risk
There are substantial experimental studies demonstrating that finerenone ameliorated endothelial impairment through upregulation of nitric oxide bioavailability and inhibition in ROS (148) and inflammatory factors, such as IL-6 and transforming growth factor- (TGF-) in the kidney (149)